Regenxbio Inc (RGNX)

EBITDA Margin

31.72%

Quarterly · Period ending:

RGNX logo

RGNX EBITDA Margin

Latest reported31.72%
RGNX Quarterly EBITDA Margin (27.95% → 31.72%)
High-resolution chart · PNG

RGNX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
31.7157%
-1,212.0444%
-168.1247%
-150.9636%
-262.0581%
20.905%
-177.9297%
-226.5405%
-217.4882%
-366.0031%
-258.1506%
-193.2351%
-332.9128%
-312.1695%
-164.4345%
-248.8722%
-179.7176%
-306.2517%
79.4%
-158.8015%
-222.7002%
-219.7839%
-175.4348%
11.0846%
-193.9515%
-215.62%
-326.3171%
-231.4966%
-445.6668%
-3,879.1855%
9.2233%
-410.5541%
18.101%
77.6933%
-778.1863%
-1,542.1407%
-218.729%
-4,916.044%
-1,165.2712%
-14,806.4%
-627.2%
-2,850.6361%
-122.9903%
-642.0175%
-460.8217%
0.3106%
-1.5679%
-5.176%
0%
27.9537%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.